Firms/companies
GlaxoSmithKline extends $2.6 billion offer for Human Genome Sciences
09 Jun 2012
No rival bids have emerged so far since GSK has invested $125 million in an ongoing research partnership with HGS and the two are collaborating on the development of three drugs
GlaxoSmithKline extends $2.6 billion offer for Human Genome Sciences
09 Jun 2012
No rival bids have emerged so far since GSK has invested $125 million in an ongoing research partnership with HGS and the two are collaborating on the development of three drugs
Don’t reappoint Infosys auditor, consultancy firm tells shareholders
09 Jun 2012
Ahead of the Infosys AGM today, Institutional Investors Advisory Services, an Indian corporate consultancy firm, has advised investors to vote against a resolution seeking the reappointment firm’s statutory auditor
Rolls-Royce buys out JV Aero Engine Controls
09 Jun 2012
Insider trading: Goldman’s Gupta may conduct own defence
09 Jun 2012
Former Goldman Sachs Group Inc board member Rajat Gupta's decision, while relatively rare, is not unprecedented in high profile white-collar crime trials
Insider trading: Goldman’s Gupta may conduct own defence
09 Jun 2012
Former Goldman Sachs Group Inc board member Rajat Gupta's decision, while relatively rare, is not unprecedented in high profile white-collar crime trials
Hathaway’s Ajit Jain to testify for Rajat Gupta
08 Jun 2012
Berkshire Hathaway's head of reinsurance business Ajit Jain will testify on behalf of former Goldman director Rajat Gupta, who is on trial for an alleged insider trading fraud
Pfizer prepares IPO for its animal healthcare unit
08 Jun 2012
The world’s largest drugmaker, Pfizer Inc, yesterday said that it is preparing to float part of its animal healthcare unit, as it plans to focus on its pharmaceuticals business
Pfizer prepares IPO for its animal healthcare unit
08 Jun 2012
The world’s largest drugmaker, Pfizer Inc, yesterday said that it is preparing to float part of its animal healthcare unit, as it plans to focus on its pharmaceuticals business